Cabotegravir was found to be 69% more effective in preventing HIV acquisition in men who have sex with men (MSM) and transgender women who have sex with men when compared to the current standard of care BOSTON , May 18, 2020 ...
A new study, titled "Transgender youth's experiences and perspectives related to HIV preventive services," by researchers at The Fenway Institute, Boston College, the Centers for Disease Control and Prevention, Division of Adolescent and School ...
A new study finds a single course of weekly rifapentine and isoniazid for three months (3HP) provides lasting protection against tuberculosis (TB) and does not need to be repeated year after year. The WHIP3TB trial led by the Aurum Institute and ...
On Tuesday, February 11, AIDS Services of Dallas (ASD) held its groundbreaking ceremony for its 511 Lancaster Project, a new affordable housing residential facility. The property, located at 511 Lancaster Avenue is the first housing development ...
HOUSTON , Jan. 27, 2020 /PRNewswire/ -- AIDS Foundation Houston Inc. (AFH), a nonprofit dedicated to ending the HIV epidemic and supporting those affected by HIV, announces a new partnership with MISTR to provide convenient access to PrEP, or ...
The human immunodeficiency virus (HIV) pipeline is robust with 450 products in active development that display a high degree of novelty and diversity. Promisingly there are 87 first-in-class products that act on a range of 50 molecular targets which ...
The human immunodeficiency virus (HIV) pipeline is robust, with 450 products in active development that display a high degree of novelty and diversity. Promisingly, there are 87 first-in-class products that act on a range of 50 molecular targets, ...
Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. , Jan. 13, 2020 /PRNewswire/ -- etectRx ™ , Inc. (etectRx ™ ), a privately-held digital health company, today announced the ID-Cap ™ System is being utilized ...
Effective January 2, 2020, Yolanda Jones Vice-President and COO of PWA Coalition of Dallas Inc., dba AIDS Services of Dallas. DALLAS , Jan. 2, 2020 /PRNewswire-PRWeb/ -- Effective January 2, 2020 , Yolanda Jones Vice-President and COO ...
Since the one year anniversary of the nationwide launch of the pre-exposure prophylaxis (PrEP) program in 11 provinces in Vietnam, the country is ready to roll out the program more widely due to global PrEP successes in reaching epidemic control ...
Eamonn Murphy’s keynote address at the End TB Dialogues Summit highlights the ongoing relevance of integrating TB and HIV services, echoing a call to action initiated by Dr. France almost two decades ago to "break the silos" for improved healthcare ...
Comprehensive treatment for all HIV -positive individuals, effectively suppressing the virus, is pivotal in curbing transmission and steering India towards an end to AIDS. ...
In a monumental leap forward in the battle against HIV/AIDS , researchers at the University of Amsterdam have reported a success in using CRISPR gene-editing technology to eliminate HIV from infected cells. This revolutionary achievement offers a ...
Initiating treatment at an early stage may contribute to sustained control of the HIV virus, provided that the treatment is consistently maintained without interruptions. ( ) People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their ...
Amsterdam UMC, with the leadership of Rogier Sanders and a grant from the Bill & Melinda Gates Foundation, is at the forefront of a global project to develop a practical HIV vaccine ( ). This would help address the significant ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers